Company / Book Value per Share
CytomX Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.718
FY2025
5-year range
-$1.295 / $0.718
FY2021-FY2025
Trend
+12708.4%
vs FY2024
Sector context
#176 of 209
Health Care
What the data says
Book Value per Share changed +12708% YoY in FY2025, a notable deviation from the 9-year average annual change of -614%.
Based on SEC 10-K filings.
$0.718 in FY2025.
Improved from -$0.705 to $0.718 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 209This company $0.718 Sector average $189.406
▼
-99.6% below sector average
Key checks
Key Insights
- CytomX Therapeutics, Inc.'s book value per share has grown for 3 consecutive years.
- In FY2025, book value per share increased 12708.4% year-over-year.
- Ranks #176 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.718 | +12708.4% |
| FY2024 | -$0.006 | +99.2% |
| FY2023 | -$0.705 | +45.6% |
| FY2022 | -$1.295 | -18346.5% |
| FY2021 | -$0.007 | +95.9% |
| FY2020 | -$0.171 | -115.2% |
| FY2019 | $1.123 | -61.3% |
| FY2018 | $2.903 | +59.8% |
| FY2017 | $1.816 | -15.5% |
| FY2016 | $2.151 | +104.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026